However, a post-hoc analysis adds to evidence suggesting that irradiating all metastatic lesions may improve survival in patients receiving immune checkpoint inhibitor monotherapy.
First study to show obesity-related cancer risk is 1.5-fold higher in people with metabolic aberrations as well as obesity, compared with metabolically healthy and normal weight individuals.
Combining Moderna s patient-specific mRNA-based cancer vaccine with pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma vs pembrolizumab alone, new data show.